Obesity as a risk factor in venous thromboembolism
- PMID: 16164883
- DOI: 10.1016/j.amjmed.2005.03.012
Obesity as a risk factor in venous thromboembolism
Abstract
Purpose: Whether obesity is an independent risk factor for pulmonary embolism or deep venous thrombosis has not been fully determined.
Methods: We used the database of the National Hospital Discharge Survey to further investigate the potential risk of obesity in venous thromboembolic disease.
Results: The relative risk of deep venous thrombosis, comparing obese patients with non-obese patients, was 2.50 (95% confidence interval [CI] = 2.49-2.51). The relative risk of pulmonary embolism was 2.21 (95% CI = 2.20-2.23). Obese females had a greater relative risk for deep venous thrombosis than obese males, 2.75 (95% CI = 2.74-2.76) versus 2.02 (95% CI = 2.01-2.04). Obesity had the greatest impact on both men and women aged less than 40 years.
Conclusion: The data indicate that obesity is a risk factor for venous thromboembolic disease in men as well as women.
Similar articles
-
Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census.Am J Med. 2004 Apr 1;116(7):435-42. doi: 10.1016/j.amjmed.2003.11.020. Am J Med. 2004. PMID: 15047032
-
Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology.Am J Med. 2004 Jul 1;117(1):19-25. doi: 10.1016/j.amjmed.2004.01.018. Am J Med. 2004. PMID: 15210384
-
Venous thrombosis after long-haul flights.Arch Intern Med. 2003 Dec 8-22;163(22):2759-64. doi: 10.1001/archinte.163.22.2759. Arch Intern Med. 2003. PMID: 14662630
-
Obesity and thromboembolic disease.Clin Chest Med. 2009 Sep;30(3):489-93, viii. doi: 10.1016/j.ccm.2009.05.006. Clin Chest Med. 2009. PMID: 19700047 Review.
-
What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?Thromb Res. 2007;119(3):265-74. doi: 10.1016/j.thromres.2006.03.010. Epub 2006 May 3. Thromb Res. 2007. PMID: 16674999 Review.
Cited by
-
Combined Donor-Recipient Obesity and the Risk of Graft Loss After Kidney Transplantation.Transpl Int. 2022 Sep 29;35:10656. doi: 10.3389/ti.2022.10656. eCollection 2022. Transpl Int. 2022. PMID: 36247488 Free PMC article.
-
Rivaroxaban Pharmacokinetics in Obese Subjects: A Systematic Review.Clin Pharmacokinet. 2022 Oct 6. doi: 10.1007/s40262-022-01160-z. Online ahead of print. Clin Pharmacokinet. 2022. PMID: 36201149
-
Efficacy and safety of pre-operative insertion of inferior vena cava filter in patients undergoing bariatric surgery: a systematic review.J Thromb Thrombolysis. 2022 Oct;54(3):502-523. doi: 10.1007/s11239-022-02689-3. Epub 2022 Aug 12. J Thromb Thrombolysis. 2022. PMID: 35960423
-
Preoperative preparation and premedication of bariatric surgical patient.Saudi J Anaesth. 2022 Jul-Sep;16(3):287-298. doi: 10.4103/sja.sja_140_22. Epub 2022 Jun 20. Saudi J Anaesth. 2022. PMID: 35898527 Free PMC article. Review.
-
Increased BMI and Blood Lipids Are Associated With a Hypercoagulable State in the Moli-sani Cohort.Front Cardiovasc Med. 2022 Jun 16;9:897733. doi: 10.3389/fcvm.2022.897733. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35783839 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
